How fasting could fight against cancer

Credit: Unsplash+

In recent years, fasting has emerged from the shadows of mere weight loss strategy to a spotlight of scientific research, especially in the realm of chronic diseases like cancer.

This dietary approach, which involves voluntarily abstaining from food and drink for a set period, has been speculated to offer potential benefits for cancer prevention and treatment.

This article dives into what current research says about fasting and its effects on cancer, breaking down complex scientific findings into understandable insights.

The Science of Fasting

Fasting is not a one-size-fits-all concept. It ranges from intermittent fasting, involving cycles of eating and fasting periods within a day or week, to prolonged fasting, which extends for more than 48 hours. Each method activates different biological pathways that could impact cancer development and progression.

One of the primary mechanisms through which fasting is believed to benefit cancer patients is by reducing the levels of insulin and glucose in the body.

Cancer cells consume more glucose than normal cells to fuel their rapid growth. By lowering glucose and insulin levels, fasting could potentially “starve” cancer cells while minimizing harm to normal cells.

Furthermore, fasting is thought to enhance the body’s response to stress and damage by activating autophagy, a process where cells remove damaged components, thereby preventing the accumulation of cellular debris that could contribute to cancer.

Additionally, fasting may strengthen the effectiveness of chemotherapy by making cancer cells more susceptible to treatment while protecting normal cells, a concept known as “differential stress resistance.”

Research Evidence

Several animal studies have provided compelling evidence supporting the benefits of fasting in cancer. For example, research in mice has shown that intermittent fasting can slow down the growth of tumors and enhance the efficacy of chemotherapy and radiation therapy. However, human studies are limited but growing.

Early clinical trials and observational studies in humans suggest that fasting may improve treatment-related side effects, reduce tumor growth rates, and enhance the effectiveness of chemotherapy.

However, the body of evidence is still in its infancy, and more rigorous, large-scale studies are needed to confirm these findings and understand the optimal fasting protocols.

Possible Risks and Considerations

While fasting could offer potential benefits, it’s not without risks, especially for cancer patients. Fasting during cancer treatment may lead to unwanted weight loss, malnutrition, and a decrease in the body’s ability to recover from treatment.

The impact of fasting on cancer is also likely to vary depending on the type of cancer, its stage, and the patient’s overall health and nutritional status.

Given these concerns, it’s crucial for cancer patients considering fasting to consult with their healthcare team. A tailored approach, taking into account the individual’s specific circumstances and health condition, is necessary.


Fasting presents a fascinating yet complex area of research in the fight against cancer. While animal studies and preliminary human research suggest potential benefits, the practice is not yet a mainstream recommendation for cancer treatment.

The road from promising early findings to established clinical practice is long and requires more comprehensive studies. Until then, fasting should be approached with caution and under professional guidance for anyone with cancer.

The hope is that ongoing and future research will shed more light on fasting’s role in cancer prevention and treatment, offering new strategies to complement conventional therapies.

If you care about cancer, please read studies that low-carb diet could increase overall cancer risk, and new way to increase the longevity of cancer survivors.

For more information about cancer, please see recent studies about how to fight cancer with these anti-cancer superfoods, and results showing daily vitamin D3 supplementation may reduce cancer death risk.

Copyright © 2024 Knowridge Science Report. All rights reserved.